|1.||Pham, Thuy: 3 articles (01/2014 - 11/2010)|
|2.||Sun, Wei: 3 articles (01/2014 - 11/2010)|
|3.||Shiau, Ai-Li: 3 articles (11/2013 - 01/2009)|
|4.||Tzai, Tzong-Shin: 3 articles (11/2013 - 01/2009)|
|5.||Tsai, Hsin-Tzu: 3 articles (11/2013 - 01/2009)|
|6.||Jou, Yeong-Chin: 3 articles (11/2013 - 01/2009)|
|7.||Tsai, Yuh-Shyan: 3 articles (11/2013 - 01/2009)|
|8.||Wu, Chao-Liang: 3 articles (11/2013 - 01/2009)|
|9.||Chao, Chuck C-K: 2 articles (11/2015 - 01/2015)|
|10.||Lin, Yi-Te: 2 articles (11/2015 - 01/2015)|
|1.||Mitral Valve Insufficiency (Mitral Regurgitation)
10/01/2010 - "PTMA is a promising technique for the treatment of severe mitral regurgitation in selected patients. "
05/01/2008 - "A PTMA device was implanted percutaneously in the CS of 10 normal sheep without mitral regurgitation. "
04/01/2007 - "The PTMA device reduced both minimum and maximal mitral annular area (9.5 +/- 0.9-7.0 +/- 0.6 and 12.8 +/- 1.3-9.8 +/- 1.5 cm(2), P < .001 for both, respectively) with reduction of mitral regurgitation jet area (5.1 +/- 2.3-1.2 +/- 0.8 cm(2), P < .001), whereas it did not significantly impair mitral annular excursion amplitude (8.3 +/- 1.1-7.0 +/- 1.9 mm, P = .13). "
01/01/2014 - "Recent clinical studies of the percutaneous transvenous mitral annuloplasty (PTMA) devices have shown a short-term reduction of mitral regurgitation after implantation. "
05/01/2013 - "PTOLEMY-2 was a prospective multicenter phase I single-arm feasibility trial to evaluate the second-generation permanent percutaneous transvenous mitral annuloplasty (PTMA) device in reducing functional mitral regurgitation (MR). "
01/01/2014 - "In this study, we identified that PTMA expression was up-regulated at both the transcriptional and translational level in tumor tissue compared to that in adjacent normal tissue. "
10/01/2009 - "The results of our study have shown that PTMA is overexpressed in UUT-TCCs and that cytoplasmic PTMA expression can provide significant prognostic information for subsequent tumor recurrence in the residual urinary tract after nephroureterectomy."
01/01/2014 - "Survival analysis revealed that the disease-free survival (DFS) and overall survival (OS) rates were significantly lower among patients with PTMA- and TP53-positive tumors. "
11/01/2013 - "Both plasma TA1 and PTMA did not correlate with tumor grade. "
11/01/2013 - "Plasma TA1 and PTMA levels were measured using enzyme-linked immunosorbent assay and their correlation with tumor grade, pathologic stage, and survival were explored. "
01/01/2012 - "Comparing our results with previous studies, we identified some genes known related to OP risk, as well as some uncovered novel osteoporosis susceptible genes ('DICER1', 'PTMA', etc.) that may function importantly in osteoporosis etiology. "
01/01/2012 - "Moreover, we uncovered novel osteoporosis susceptible genes ('DICER1', 'PTMA', etc.) that were not found previously but play functionally important roles in osteoporosis etiology from existing studies. "
|4.||Prostatic Neoplasms (Prostate Cancer)
04/01/2006 - "The present study clearly demonstrated that PTMA expression is intimately involved in the differentiation and progression of human prostate cancers, and could be a target for therapy and diagnostic purposes."
04/01/2006 - "The purpose of the present investigation was to provide a better understanding of the role of PTMA in human prostate cancers. "
04/01/2006 - "PTMA expression in 68 prostate cancer cases and in prostate cancer cell lines was examined by immunohistochemistry and immunoblotting, and its levels were increased with progression from normal epithelium, through prostatic intraepithelial neoplasia (PIN) to carcinomas, correlating with the Gleason's pattern. "
03/01/2007 - "In four patients, SEREX immunoscreening of a prostate cancer cDNA expression library identified several antigens recognized by treatment-associated autoantibodies, including PARP1, ZNF707 + PTMA, CEP78, SDCCAG1, and ODF2. "
|5.||Neurodegenerative Diseases (Neurodegenerative Disease)
|3.||Complementary DNA (cDNA)
|4.||Messenger RNA (mRNA)
|5.||Proteins (Proteins, Gene)
|6.||glucuronyl glucosamine glycan sulfate (Vessel)
|9.||Small Interfering RNA (siRNA)
|10.||1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)
|1.||Mitral Valve Annuloplasty
|4.||Hematopoietic Stem Cell Transplantation
|5.||Heterologous Transplantation (Xenotransplantation)